AQSTAquestive Therapeutics, Inc.

Nasdaq aquestive.com


$ 3.08 $ -0.29 (-8.73 %)    

Wednesday, 08-May-2024 15:59:31 EDT
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 3.085
$ 3.18
$ 0.00 x 0
$ 0.00 x 0
$ 2.92 - $ 3.19
$ 1.25 - $ 6.23
2,728,150
na
227.1M
$ 1.79
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 03-05-2024 12-31-2023 10-K
3 11-06-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-02-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-01-2022 09-30-2022 10-Q
8 08-02-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 03-08-2022 12-31-2021 10-K
11 11-02-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 03-09-2021 12-31-2020 10-K
15 11-04-2020 09-30-2020 10-Q
16 08-04-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 03-11-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-14-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 09-04-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aquestive-therapeutics-continues-to-expect-fy24-total-revenue-of-48m-51m-est-50214m

Cash and cash equivalents were $95.2 million as of March 31, 2024. Extended cash runway into 2026 with completion of $77.5 mill...

 aquestive-therapeutics-q1-2024-gaap-eps-017-misses-007-estimate-sales-12053m-miss-12262m-estimate

Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate...

 hc-wainwright--co-reiterates-buy-on-aquestive-therapeutics-maintains-9-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Buy and maintains ...

 piper-sandler-initiates-coverage-on-aquestive-therapeutics-with-overweight-rating-announces-price-target-of-10

Piper Sandler analyst David Amsellem initiates coverage on Aquestive Therapeutics (NASDAQ:AQST) with a Overweight rating and...

 hc-wainwright--co-reiterates-buy-on-aquestive-therapeutics-maintains-9-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Buy and maintains ...

 why-staar-surgical-shares-are-trading-higher-by-around-13-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong prelimi...

 lamb-weston-reports-weak-earnings-joins-paragon-28-resources-connection-and-other-big-stocks-moving-lower-on-thursday

U.S. stocks were higher, with the Dow Jones gaining over 150 points on Thursday.

 raymond-james-initiates-coverage-on-aquestive-therapeutics-with-outperform-rating-announces-price-target-of-7

Raymond James analyst Gary Nachman initiates coverage on Aquestive Therapeutics (NASDAQ:AQST) with a Outperform rating and a...

 dow-surges-350-points-fed-holds-rates-steady

U.S. stocks traded higher toward the end of trading, after the Federal Reserve left rates unchanged. The Dow traded up 0.91% t...

 why-lifecore-biomedical-shares-are-trading-lower-by-around-32-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it con...

 crude-oil-dips-2-signet-jewelers-shares-spike-higher

U.S. stocks traded mostly flat midway through trading, ahead of interest-rate decision from the Federal Reserve. The Dow trade...

 why-taysha-gene-therapies-shares-are-trading-higher-by-around-27-here-are-20-stocks-moving-premarket

Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a y...

 harrow-posts-weak-q4-results-joins-terawulf-nasdaq-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% on Wednesday.

 reported-earlier-aquestive-therapeutics-prices-75m-underwritten-public-offering-of-16666667-common-shares-at-450share

The gross proceeds of the offering to Aquestive, before deducting the underwriting discounts and commissions and other offering...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION